Equity benchmarks added to gains early Monday after Moderna Inc. (MRNA) said its vaccine candidate proved 94.5% effective in preventing COVID-19 infections, as investors looked past a continued surge in new cases of the disease and the lack of progress toward another round of aid for strapped consumers. The Moderna news comes a week after Pfizer Inc. [s" PFE] and BioNTech SE (BNTX) announced the first effective COVID-19 vaccine, which has sparked an equity rally and a violent rotation out of stocks that have benefited from the stay-at-home environment and into those considered value by some metric. The Dow Jones Industrial Average rose 340 points, or 1.2%, at 29,819 the S&P 500 index rose gained 0.7% to reach 3,611, while the Nasdaq Composite Index was up about 0.1% at 11,836. In economic data ( ), the New York Fed's Empire State business conditions index fell 4.2 points to 6.3 in November, the regional Fed bank said Monday. Economists had expected a reading of 13.5, according to a survey by Econoday. In corporate news, shares of Casper Sleep Inc. (CSPR)tumbled in premarket trading ( ) Monday, after the mattress-in-a-box seller reported a wider-than-expected third-quarter loss on revenue that surprisingly declined, citing supply-chain challenges given as a result of the COVID-19 pandemic. In deal news, PNC Financial Services Group Inc. (PNC) agreed to buy the U.S. arm of Spain's BBVA for $11.6 billion, the companies said Monday, in one of the largest bank tie-ups since the financial crisis.
-Mark DeCambre; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
November 16, 2020 09:33 ET (14:33 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.